| Company Name | Exchange | Ticker | Last Price | Day 1 (% Change) | Day 2 (% Change) | 52 WEEK HIGH | 52 WEEK LOW | Last Volume | M.Cap MM ($) |
| Abattis Bioceuticals Corp | CNSX | ATT | 0.58 | 7.9% | 20.8% | 3.10 | 0.02 | 2,110,836 | 27.6 |
| Theralase Technologies Inc | TSXV | TLT | 0.36 | 5.0% | 12.7% | 0.56 | 0.17 | 3,231,176 | 23.6 |
These two junior Canadian healthcare stocks are featured as top stocks of the day based on their price performance during previous trading sessions. These stocks recorded a strong price gain momentum during the past two trading session with significant volumes.
Abattis Bioceuticals Corp (CNSX: ATT), engaged in research, development and manufacturing natural botanical formulations to prevent or treat influenza strains in birds, humans and other mammals, gained more than 30% during its past two trading sessions gaining more than 8% in each of the two consecutive days. During its last trading session, the stock powered 20.8% higher closing at $0.58 with significant trading volumes of 2.11 million shares. During its past 5-trading sessions, ATT surged 34.9% with 5-day average volume of 1.3 million shares compared to 1-month daily average volume of 799,678 shares.
Theralase Technologies Inc (TSX-V: TLT), engaged in designing, developing, manufacturing and marketing patented, super-pulsed laser technology used in biostimulative and biodestructive clinical applications, gained more than 18% during its past two trading sessions gaining more than 5% in each of the two consecutive days. During its last trading session, the stock powered 12.7% higher closing at $0.36 with significant trading volumes of 3.23 million shares. During its past 5-trading sessions, TLT surged 12.7% with 5-day average volume of 1.2 million shares compared to 1-month daily average volume of 2.2 million shares.
